| - GRCh37:
- Chr6:47541979
- GRCh38:
- Chr6:47574243
| CD2AP | P241T | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Dec 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47470996
- GRCh38:
- Chr6:47503260
| CD2AP | | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Likely benign (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47576851
- GRCh38:
- Chr6:47609115
| CD2AP | | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Likely benign (Aug 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47567019-47567020
- GRCh38:
- Chr6:47599283-47599284
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to, not provided | Benign/Likely benign (Sep 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47577038
- GRCh38:
- Chr6:47609302
| CD2AP | | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Likely benign (Jun 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47501483
- GRCh38:
- Chr6:47533747
| CD2AP | I104N | Focal segmental glomerulosclerosis 3, susceptibility to, not provided | Uncertain significance (Mar 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47541809
- GRCh38:
- Chr6:47574073
| CD2AP | L184S | Focal segmental glomerulosclerosis 3, susceptibility to, not provided | Uncertain significance (Apr 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47576982
- GRCh38:
- Chr6:47609246
| CD2AP | L586F | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Nov 27, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47576960-47576961
- GRCh38:
- Chr6:47609224-47609225
| CD2AP | N581fs | Focal segmental glomerulosclerosis 3, susceptibility to | Pathogenic (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47501422
- GRCh38:
- Chr6:47533686
| CD2AP | R84* | Focal segmental glomerulosclerosis 3, susceptibility to | Pathogenic (Jul 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47541894
- GRCh38:
- Chr6:47574158
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to, not provided | Benign/Likely benign (Jul 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47522408
- GRCh38:
- Chr6:47554672
| CD2AP | | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Benign/Likely benign (Sep 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47501347-47501348
- GRCh38:
- Chr6:47533611-47533612
| CD2AP | E60fs | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47573971
- GRCh38:
- Chr6:47606235
| CD2AP | M496I | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47522482
- GRCh38:
- Chr6:47554746
| CD2AP | H174P | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Feb 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47471037
- GRCh38:
- Chr6:47503301
| CD2AP | D9G | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (May 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47544293-47544294
- GRCh38:
- Chr6:47576557-47576558
| CD2AP | S256fs | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Pathogenic/Likely pathogenic (May 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47594080
- GRCh38:
- Chr6:47626344
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47593881
- GRCh38:
- Chr6:47626145
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47591964
- GRCh38:
- Chr6:47624228
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47575726
- GRCh38:
- Chr6:47607990
| CD2AP | P532S | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47522413
- GRCh38:
- Chr6:47554677
| CD2AP | N151S | Inborn genetic diseases, Focal segmental glomerulosclerosis 3, susceptibility to | Conflicting interpretations of pathogenicity (May 9, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:47501393
- GRCh38:
- Chr6:47533657
| CD2AP | R74M | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Mar 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47501354
- GRCh38:
- Chr6:47533618
| CD2AP | T61M | Focal segmental glomerulosclerosis 3, susceptibility to, not provided, Inborn genetic diseases
| Uncertain significance (Nov 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47471189
- GRCh38:
- Chr6:47503453
| CD2AP | | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Benign/Likely benign (Aug 11, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47592980
- GRCh38:
- Chr6:47625244
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592725
- GRCh38:
- Chr6:47624989
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592669
- GRCh38:
- Chr6:47624933
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47574025
- GRCh38:
- Chr6:47606289
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to, not provided | Benign (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47563652
- GRCh38:
- Chr6:47595916
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47445912
- GRCh38:
- Chr6:47478176
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47445815
- GRCh38:
- Chr6:47478079
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594511
- GRCh38:
- Chr6:47626775
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594433
- GRCh38:
- Chr6:47626697
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592512
- GRCh38:
- Chr6:47624776
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592467
- GRCh38:
- Chr6:47624731
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47563636
- GRCh38:
- Chr6:47595900
| CD2AP | A383E | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47544782
- GRCh38:
- Chr6:47577046
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47544287
- GRCh38:
- Chr6:47576551
| CD2AP | K253E | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594357
- GRCh38:
- Chr6:47626621
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594284
- GRCh38:
- Chr6:47626548
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594272
- GRCh38:
- Chr6:47626536
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592289
- GRCh38:
- Chr6:47624553
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592260
- GRCh38:
- Chr6:47624524
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592129
- GRCh38:
- Chr6:47624393
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592123
- GRCh38:
- Chr6:47624387
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47544253
- GRCh38:
- Chr6:47576517
| CD2AP | | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Likely benign (Sep 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47541933
- GRCh38:
- Chr6:47574197
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47541789
- GRCh38:
- Chr6:47574053
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47544260
- GRCh38:
- Chr6:47576524
| CD2AP | P244S | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jul 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47541928
- GRCh38:
- Chr6:47574192
| CD2AP | S224P | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Oct 28, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr6:47548626
- GRCh38:
- Chr6:47580890
| CD2AP | | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Benign/Likely benign (Sep 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47471053
- GRCh38:
- Chr6:47503317
| CD2AP | | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Benign/Likely benign (Sep 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47576867
- GRCh38:
- Chr6:47609131
| CD2AP | | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Likely benign (Oct 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47576922
- GRCh38:
- Chr6:47609186
| CD2AP | P566S | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Likely benign (May 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47548605
- GRCh38:
- Chr6:47580869
| CD2AP | | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Benign/Likely benign (May 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47573999
- GRCh38:
- Chr6:47606263
| CD2AP | N506D | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47567141
- GRCh38:
- Chr6:47599405
| CD2AP | D460fs | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Nov 22, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47548637
- GRCh38:
- Chr6:47580901
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Pathogenic (Oct 16, 2017) | no assertion criteria provided |
| - GRCh37:
- Chr6:47544838
- GRCh38:
- Chr6:47577102
| CD2AP | K301M | Focal segmental glomerulosclerosis 3, susceptibility to, not provided, not specified
| Uncertain significance (Jul 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47594722
- GRCh38:
- Chr6:47626986
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594668
- GRCh38:
- Chr6:47626932
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594412
- GRCh38:
- Chr6:47626676
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594408
- GRCh38:
- Chr6:47626672
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594332
- GRCh38:
- Chr6:47626596
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594318
- GRCh38:
- Chr6:47626582
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594302
- GRCh38:
- Chr6:47626566
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594204
- GRCh38:
- Chr6:47626468
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594195
- GRCh38:
- Chr6:47626459
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594081
- GRCh38:
- Chr6:47626345
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594002
- GRCh38:
- Chr6:47626266
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47594000
- GRCh38:
- Chr6:47626264
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47593890
- GRCh38:
- Chr6:47626154
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47593569
- GRCh38:
- Chr6:47625833
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47593171
- GRCh38:
- Chr6:47625435
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592829
- GRCh38:
- Chr6:47625093
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592791
- GRCh38:
- Chr6:47625055
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592670
- GRCh38:
- Chr6:47624934
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592615
- GRCh38:
- Chr6:47624879
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592465
- GRCh38:
- Chr6:47624729
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592463
- GRCh38:
- Chr6:47624727
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592461
- GRCh38:
- Chr6:47624725
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592459
- GRCh38:
- Chr6:47624723
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592457
- GRCh38:
- Chr6:47624721
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592455
- GRCh38:
- Chr6:47624719
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592415
- GRCh38:
- Chr6:47624679
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592282
- GRCh38:
- Chr6:47624546
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47592149
- GRCh38:
- Chr6:47624413
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47591983
- GRCh38:
- Chr6:47624247
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47576899
- GRCh38:
- Chr6:47609163
| CD2AP | A558V | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Benign/Likely benign (Oct 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47576877
- GRCh38:
- Chr6:47609141
| CD2AP | T551A | Focal segmental glomerulosclerosis 3, susceptibility to | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47576853
- GRCh38:
- Chr6:47609117
| CD2AP | | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Uncertain significance (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47575700-47575702
- GRCh38:
- Chr6:47607964-47607966
| CD2AP | E525del | not provided, Focal segmental glomerulosclerosis | Uncertain significance (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47575648
- GRCh38:
- Chr6:47607912
| CD2AP | | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Benign (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47567166
- GRCh38:
- Chr6:47599430
| CD2AP | | Focal segmental glomerulosclerosis 3, susceptibility to | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr6:47563676
- GRCh38:
- Chr6:47595940
| CD2AP | | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Likely benign (Feb 9, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47563669
- GRCh38:
- Chr6:47595933
| CD2AP | P394Q | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Benign/Likely benign (Jul 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr6:47547209
- GRCh38:
- Chr6:47579473
| CD2AP | L331H | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Conflicting interpretations of pathogenicity (Sep 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:47541940
- GRCh38:
- Chr6:47574204
| CD2AP | R228W | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr6:47541811
- GRCh38:
- Chr6:47574075
| CD2AP | A185S | not provided, Focal segmental glomerulosclerosis 3, susceptibility to | Conflicting interpretations of pathogenicity (Oct 23, 2022) | criteria provided, conflicting interpretations |